Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
1 S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
06:21am, Monday, 04'th Mar 2024
This stock has plunged in recent years mainly because of declining demand for two of its key products. However, it's poised to return to growth, is dirt cheap, and pays an especially juicy dividend.
3 Volatility-Busting, Low-Beta Stocks to Grab Now
08:00am, Sunday, 03'rd Mar 2024
The S&P 500 has been trending higher by 7% in the first two months of 2024. While sentiments seem positive, the markets need to navigate blowing macroeconomic headwinds.
1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
07:30am, Sunday, 03'rd Mar 2024
The fading interest in combating COVID-19 has taken a toll on Pfizer's top and bottom lines. Pfizer stock has risen and fallen with its coronavirus business, but the pullback has been exaggerated.
Hot on the Hedge Funds' Trail: 3 Stocks Worth Your Bet?
01:00pm, Saturday, 02'nd Mar 2024
The fourth quarter (Q4) shined bright for hedge funds, marking it a standout period in the investment realm. According to a recent report released by a U.K.-based data investment business, global hedg
3 Overhyped Stocks Every Smart Investor Should Ignore
06:30am, Friday, 01'st Mar 2024
The U.S. stock market started the year with an unusual divergence, suggesting overhyped stocks. The S&P 500 hit an all-time high level at 7.3% year-to-date (YTD) rise.
Pfizer says its RSV shot is protective through a second year
08:04am, Thursday, 29'th Feb 2024
Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness through a second year of respiratory disease se
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
08:00am, Thursday, 29'th Feb 2024
The results come ahead of a meeting of an advisory panel to the CDC, which will consider whether seniors should take RSV shots annually or every other year.
3 Starter Long-Term Stocks Every New Investor Should Own
01:16pm, Wednesday, 28'th Feb 2024
Given the uncertainty in financial markets, long-term stocks for new investors are probably the way to go now. These assets promise healthy long-term growth while trading at attractive prices based on
3 Forgotten Dividend Stocks With a Yield of Over 5%
10:07am, Wednesday, 28'th Feb 2024
Before discussing about some undervalued and attractive dividend stocks, let's briefly talk about the investing psychology. A Forbes article on “The Psychology of Investing” points out that “inv
7 Dividend Stocks to Buy to Secure Steady Income
09:50am, Wednesday, 28'th Feb 2024
While making income investments, finding avenues that offer stable inflow even against market fluctuations is similar to discovering hidden treasures. For the perfect blend of reliability and growth,
4 Fortune 500 Industry Leaders For February Dividends
12:20pm, Tuesday, 27'th Feb 2024
The Summer 2023 edition of Fortune Magazine revealed the 500 biggest U.S. companies by revenue. Dogcatcher's quest to sniff out the best dividend buys focused on 68 industry leaders.
Should You Pick Pfizer Stock At $30 After A 30% Fall In A Year?
09:00am, Tuesday, 27'th Feb 2024
Pfizer PFE (NYSE: PFE) reported its Q4 results last month, with revenues missing but earnings beating the street estimates. The company reported revenue of $14.2 billion and an adjusted profit of $0.1
Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst
05:40am, Tuesday, 27'th Feb 2024
Pfizer's dividend yield is 50% higher than its historical average right now. Pfizer's latest acquisition could lead to a resurgence in growth -- but it doesn't have to.
7 Defensive Stocks to Weather Any Downturn With Ease
03:33pm, Monday, 26'th Feb 2024
With the Dow Jones closing at a fresh record recently, targeting defensive stocks might seem like overkill. You want to be careful in the capital market, no doubt about it.
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
02:44pm, Monday, 26'th Feb 2024
In the stock market, finding solid blue-chip stocks can lead to substantial portfolio growth. While the hype of flashy stocks often gets headlines, the steady performers driving constant returns truly
